The results were confirmed by the PP analysis , with @/@ ( @ % ) cured patients in the linezolid group versus @/@ ( @ % ) in the trimethoprim/sulfamethoxazole and rifampicin group ( risk difference @ % , @ % CI -@ % to @ % ) .